Global Over The Counter Or OTC Test Outlook 2025, Forecast To 2034
26 Mar, 2025
What Has Been the Growth of the Over The Counter Or OTC Test Market So Far?
The over the counter or otc test market has seen considerable growth due to a variety of factors.
• The market size of the over the counter (OTC) test has seen significant growth recently. It is predicted that its value will increase from $24.10 billion in 2024 to an impressive $27.55 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.3%.
Factors contributing to its growth during the historic period include the emergence of smart home healthcare, an increase in remote patient monitoring, expansion of outpatient clinics, the advancement of mHealth (mobile health) solutions and the proliferation of subscription-based services.
How Will the Over The Counter Or OTC Test Market?
The over the counter or otc test market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for over the counter or OTC tests is predicted to experience a significant surge in the approaching years. The market is estimated to reach $46.38 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.9%.
This growth within the projected timeframe can be accredited to the increased occurrence of infectious illnesses, an escalating count of HIV patients, the rise in remote patient supervision, expanding smartphone penetration, and an increase in healthcare-associated infections (HAIS). The anticipated period will be marked by major trends such as the incorporation of digital health, compatibility with mobile applications, integrated care models, the implementation of artificial intelligence and machine learning, and the monitoring of remote infection control.
Which Factors Are Boosting Growth In The Over The Counter Or OTC Test Market?
The surge in chronic illnesses is anticipated to fuel the expansion of the over the counter (OTC) test market. Chronic diseases are long-term conditions that persist for over a year, requiring consistent medical care or limiting routine activities. The rise in chronic diseases is motivated by aspects like aging populations, unhealthy lifestyles, environmental impacts, mental well-being, and socioeconomic standing. OTC tests contribute to chronic disease management by allowing early identification, enabling individuals to keep check on their health, and making prompt interventions possible. They also enhance health results by encouraging preventative care. For example, the US National Library of Medicine's National Center for Biotechnology Information (NCBI) estimated in January 2023 that by 2050, the number of people over 50 with at least one chronic disease will escalate by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Therefore, the escalation in chronic disease incidence is propelling the growth of the OTC test market.
What Key Areas Define The Segmentation Of The Global Over The Counter Or OTC Test Market?
The over the counter or OTC test market covered in this report is segmented –
1) By Product: Cholesterol Monitoring Test, Urine Analysis Test, Drug Abuse Test, Infectious Disease Testing, Fecal Occult Test, Glucose Monitoring Test
2) By Application: Cardiology, Oncology, Glucose Monitoring, Pregnancy And Fertility, Infectious Disease, Toxicology
3) By End-User: Hospital And Clinic, Home Care, Diagnostic Laboratory, Other End-Users
Subsegments:
1) By Cholesterol Monitoring Test: Total Cholesterol Test, HDL (High-Density Lipoprotein) Test, LDL (Low-Density Lipoprotein) Test, Triglycerides Test
2) By Urine Analysis Test: Urine Dipstick Test, Urine Microscopy Test, Urine Culture Test, Urine Pregnancy Test
3) By Drug Abuse Test: Urine Drug Test, Saliva Drug Test, Hair Follicle Drug Test, Breath Drug Test
4) By Infectious Disease Testing: HIV Test, Hepatitis Test, Influenza Test, COVID-19 Test, Strep Throat Test
5) By Fecal Occult Test: Guaiac-Based Fecal Occult Blood Test (gFOBT), Immunochemical Fecal Occult Blood Test (iFOBT/FIT)
6) By Glucose Monitoring Test: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Systems, Urine Glucose Test Strips
What New Trends Are Influencing The Over The Counter Or OTC Test Market?
Leading firms involved in the over the counter (OTC) test market are redirecting their focus towards innovating advanced products like at-home test kits aiming to improve convenience, precision, and reachability for customers. These at-home testing kits are specially crafted for personal use, facilitating individuals to self-diagnose certain health issues or diseases. The procedure typically involves gathering samples such as blood, saliva, and urine and swiftly delivering results. For example, DiaCarta, an American molecular diagnostics firm, was granted its OTC iColon Fecal Occult Blood Test (FOBT) in December 2023, subsequent to earning US FDA 510(k) clearance. This revolutionary test is essential in early detection of blood in feces, a vital sign in identifying gastrointestinal disorders and colorectal cancer which is the third most highly diagnosed cancer across the globe. The iColon FOBT amplifies DiaCarta's pre-existing ColoScape Test, further enriching the company’s pledge to provide sophisticated healthcare solutions aimed to enhance early cancer detection and intervention.
Who Are the Key Players In The Over The Counter Or OTC Test Market?
Major companies operating in the over the counter or OTC test market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Siemens Healthineers AG
• Becton
• Dickinson and Company (BD)
• QuidelOrtho Corporation
• Kroger Health
• Dexcom Inc.
• Bio-Rad Laboratories Inc.
• SD Biosensor Inc.
• OraSure Technologies Inc.
• Everlywell Inc.
• LetsGetChecked Inc.
• Bionime Corporation
• Nipro Diagnostics Inc.
• Chembio Diagnostics Inc.
• ACON Laboratories Inc.
• iHealth Labs Inc.
• Ellume Limited
• Geratherm Medical AG
• Wondfo Biotech Co. Ltd.
• bioLytical Laboratories Inc.
• Watmind USA
• First Check Diagnostics LLC
What Is The Most Dominant Region In The Over The Counter Or OTC Test Market?
North America was the largest region in the over the counter or OTC test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over the counter or OTC test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.